2026-2034年全球神經內科栓塞器材市場規模、佔有率、趨勢及成長分析報告

預計神經病學領域栓塞裝置的市場規模將從 2025 年的 18.4 億美元成長到 2034 年的 32.4 億美元，2026 年至 2034 年的複合年成長率為 6.48%。

由於腦動脈瘤和動靜脈畸形等神經系統疾病的發生率不斷上升，全球神經栓塞器械市場正在不斷擴大。這些疾病通常需要使用栓塞器械進行微創手術來阻塞異常血管。人們對早期診斷和治療神經系統疾病重要性的認知不斷提高，顯著增加了對這些專用醫療設備的需求。

神經血管介入技術的進步是市場成長的關鍵。先進彈簧圈、液體栓塞劑和血流導向裝置的研發提高了治療的精確度和患者預後。此外，神經血管治療中心的增加和微創手術的廣泛應用也推動了對栓塞技術的需求。

未來幾年，介入神經放射學器材的持續創新和神經系統研究投入的增加預計將對市場產生正面影響。神經系統疾病發生率的上升趨勢以及新興國家醫療基礎設施的擴張也將推動市場成長。隨著醫療技術的進步，栓塞手術有望變得更加安全，並得到更廣泛的應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球神經內科栓塞器材市場：依產品分類

• 市場分析、洞察與預測
• 栓塞線圈
• 液體栓塞系統
• 血流導向支架
• 動脈瘤夾
• 其他產品

第5章：全球神經內科栓塞器材市場：依治療類型分類

• 市場分析、洞察與預測
• 缺血性中風治療方案
• 出血性中風治療方案

第6章：全球神經內科栓塞器材市場：依適應症分類

• 市場分析、洞察與預測
• 腦動脈瘤
• 動靜脈畸形
• 其他跡象

第7章：全球神經內科栓塞器材市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他最終用戶

第8章：全球神經內科栓塞器材市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Johnson & Johnson
  • Abbott Laboratories
  • Medtronic Plc
  • Heraeus Holding
  • Stryker Corporation
  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co. Ltd
  • MicroVention Inc

The Embolization Devices For Neurology Market size is expected to reach USD 3.24 Billion in 2034 from USD 1.84 Billion (2025) growing at a CAGR of 6.48% during 2026-2034.

The global embolization devices for neurology market is expanding due to the increasing prevalence of neurological disorders such as brain aneurysms and arteriovenous malformations. These conditions often require minimally invasive procedures where embolization devices are used to block abnormal blood vessels. Rising awareness about early diagnosis and treatment of neurological conditions has significantly increased the demand for these specialized medical devices.

Technological advancements in neurovascular intervention have played a key role in market growth. The development of advanced coils, liquid embolic agents, and flow-diverting devices has improved treatment precision and patient outcomes. Additionally, the growing number of neurovascular treatment centers and increased adoption of minimally invasive procedures are supporting the demand for embolization technologies.

In the coming years, the market is expected to benefit from continuous innovation in neurointerventional devices and increasing investments in neurological research. The rising burden of neurological diseases and expanding healthcare infrastructure in emerging economies are also likely to drive market expansion. As medical technology advances, embolization procedures are expected to become safer and more widely accessible.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Embolization Coils
• Liquid Embolic Systems
• Flow Diversion Stents
• Aneurysm Clips
• Other Products

By Treatment

• Ischemic Stroke Solution
• Hemorrhagic Stroke Solutions

By Indication

• Brain Aneurysms
• Arteriovenous Malformation
• Other Indications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Johnson Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Embolization Coils Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Liquid Embolic Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Flow Diversion Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Aneurysm Clips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Ischemic Stroke Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hemorrhagic Stroke Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Brain Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Arteriovenous Malformation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Treatment
  • 8.2.3 By Indication
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Treatment
  • 8.3.3 By Indication
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Treatment
  • 8.4.3 By Indication
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Treatment
  • 8.5.3 By Indication
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Treatment
  • 8.6.3 By Indication
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 Abbott Laboratories
  • 10.2.3 Medtronic Plc
  • 10.2.4 Heraeus Holding
  • 10.2.5 Stryker Corporation
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Kaneka Corporation
  • 10.2.8 Terumo Corporation
  • 10.2.9 B. Braun Melsungen AG
  • 10.2.10 Cook Medical LLC
  • 10.2.11 Integer Holdings Corporation
  • 10.2.12 Merit Medical Systems Inc
  • 10.2.13 Penumbra Inc
  • 10.2.14 Asahi Intecc Co. Ltd
  • 10.2.15 MicroVention Inc